Recent research has demonstrated that ApoC-III has a multifaceted impact on various pathophysiological processes, including triglyceride-rich lipoprotein metabolism, inflammatory responses, atherosclerosis progression, glucose metabolism, and cardiovascular diseases (38). This evidence concerns the gene APOC3 and cardiovascular disorder.